BIO-key International is trading at $2.34, down 5.65%, with no confirmed company-specific catalyst for its November 4 decline.
- The November 3 Cipher integration announcement is positive in description, but available sources do not connect it to the decline.
- The broader market is reported sharply higher, so market-wide weakness does not explain the stock’s opposite-direction move.